Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of...
Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin PR Newswire NEW YORK, July 24, 2014...
iCo Therapeutics Announces Director Election Results From Its Annual Meeting of Shareholders PR Newswire VANCOUVER, June 30, 2014 VANCOUVER, June...
iCo Therapeutics Announces Top-Line Primary Endpoint Data from iCo-007 Phase 2 iDEAL Study in Diabetic Macular Edema PR Newswire VANCOUVER, June...
iCo Therapeutics Announces First Quarter 2014 Financial Results PR Newswire VANCOUVER, May 29, 2014 VANCOUVER, May 29, 2014 /PRNewswire/ - iCo...
iCo Therapeutics Announces Poster Presentation at ARVO PR Newswire VANCOUVER, April 29, 2014 VANCOUVER, April 29, 2014 /PRNewswire/ - iCo...
iCo Therapeutics Announces Year End 2013 Financial Results PR Newswire VANCOUVER, April 24, 2014 VANCOUVER, April 24, 2014 /PRNewswire/ - iCo...
iCo Therapeutics Announces Final Eight Month Patient Visit in Phase 2 iDEAL Study PR Newswire VANCOUVER, March 5, 2014 VANCOUVER, March 5, 2014...
iCo Therapeutics Announces DTC Approval PR Newswire VANCOUVER, Feb. 25, 2014 VANCOUVER, Feb. 25, 2014 /PRNewswire/ - iCo Therapeutics Inc...
iCo Therapeutics Inc. Completes C$6.75 Million Equity Financing PR Newswire VANCOUVER, Jan. 27, 2014 VANCOUVER, Jan. 27, 2014 /PRNewswire/ - iCo...
iCo Therapeutics Inc. Announces C$6.75 Million Equity Financing PR Newswire VANCOUVER, Jan. 22, 2014 VANCOUVER, Jan. 22, 2014 /PRNewswire/ - iCo...
iCo Therapeutics Inc. Announces Overnight Marketed Equity Offering PR Newswire VANCOUVER, Jan. 21, 2014 VANCOUVER, Jan. 21, 2014 /PRNewswire/...
iCo Therapeutics Begins Trading on the OTCQX Marketplace PR Newswire VANCOUVER, Dec. 20, 2013 VANCOUVER, Dec. 20, 2013 /PRNewswire/ - iCo...
iCo Therapeutics Announces Program and Intellectual Property Advancements for Oral Amphotericin B PR Newswire VANCOUVER, Dec. 12, 2013 VANCOUVER...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지